PureTech Health plc (LSE:PRTC) said it will publish its results for the six months ended 30 June 2026 on Tuesday, 22 September 2026.
The company will hold a presentation and conference call at 9:00 a.m. BST on the same day. A webcast of the event will also be available through PureTech Health’s investor relations website.
The scheduled results will provide an update on the company’s financial performance and operations during the first half of 2026.
More about PureTech Health
PureTech Health plc is a biotherapeutics company that uses a hub-and-spoke model to develop therapies based on validated pharmacology for conditions with unmet patient needs.
The company’s research and development activities have generated multiple therapeutic candidates, including three drugs that have received approval from the U.S. Food and Drug Administration.
PureTech uses dedicated structures supported by external capital to develop certain therapeutic assets, allowing multiple programmes to progress in parallel. The company is listed on the London Stock Exchange under the ticker PRTC.
Leave a Reply